NICE Diagnosis and Management of Irritable Bowel Syndrome in Primary Care
Patients should be encouraged to become more involved in the care and management process by establishing a good patient- professional relationship. In this way, healthcare professionals can assess patients’ knowledge on the assigned prescriptions, as well as their possible reasons for non- adherence.

 

NICE states that in people who meet the IBS diagnostic criteria, the following tests should be undertaken to exclude other diagnosis:
  • Full blood count (FBC)
  • Erythrocyte sedimentation rate (ESR) or plasma viscousity
  • C-reactive protein (CRP)
  • Antibody testing for coeliac disease (endomysial antibodies [EMA] or tissue transglutaminase [TTG])
The key aspects of the NICE guideline include establishing a diagnosis, referral into secondary care only after identification of “red flags” (symptoms and/ or features that may be caused by another condition that needs investigation); providing lifestyle advice; drug and psychological interventions; and referral and follow- up.     

 

Dietary and lifestyle advice should include information on general lifestyle, physical activity, diet and symptom- targeted medication. Treatment and care should take into account patients’ needs and preferences. Good communication between health-care professionals, supported by evidence based recorded information tailored to the patient’s needs is essential. Treatment and care, and the information patients are given about it should be culturally appropriate.  

 

Customized assessments, facilitating the record of detailed lifestyle information, are one of the most beneficial features of Cellma for the diagnosis and care of this disorder. Cellma also allows for the easy referral of patients into secondary care, follow up; and provides a comprehensive way of outlining the necessary treatment and management of IBS.  

 

For more information: Irritable Bowel Syndrome

For further information or for a demonstration please contact This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

 

Last Updated ( Monday, 07 February 2011 )